NCT00787319View on ClinicalTrials.gov

Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice

CompletedOBSERVATIONAL
Enrollment

108

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Age-related Macular Degeneration
Interventions
OTHER

no intervention

Outpatients with age-related macular degeneration (AMD)

Trial Locations (11)

12808

Pfizer Investigational Site, Prague

40113

Pfizer Investigational Site, Ústí nad Labem

62500

Pfizer Investigational Site, Brno

70852

Pfizer Investigational Site, Ostrava - Poruba

77520

Pfizer Investigational Site, Olomouc

625 00

Pfizer Investigational Site, Brno

775 20

Pfizer Investigational Site, Olomouc

304 60

Pfizer Investigational Site, Pilsen

128 08

Pfizer Investigational Site, Prague

169 00

Pfizer Investigational Site, Prague

169 02

Pfizer Investigational Site, Prague

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00787319 - Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice | Biotech Hunter | Biotech Hunter